Rights to Clinical Stage Compound for Dry Eye (civamide) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Rights to Clinical Stage Compound for Dry Eye (civamide) General Information

Description

Medicine for treatment of dry eye disease. The rights include the clinical stage compound used for the treatment of dry eye.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
+1 (305) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rights to Clinical Stage Compound for Dry Eye (civamide) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rights to Clinical Stage Compound for Dry Eye (civamide)‘s full profile, request access.

Request a free trial